DNA vaccines: An evolving approach to the treatment of allergic disorders
Author: Broide, David H.
Source: Allergy and Asthma Proceedings, Volume 26, Number 3, May-June 2005 , pp. 195-198(4)
Publisher: OceanSide Publications, Inc
Abstract:Immunotherapy with protein allergens is effective in modulating the immune response and reducing symptoms in patients with allergic rhinitis and asthma. Unfortunately, the dose of allergen that can be administered to allergic asthmatic patients, who might most benefit from this form of therapy, is frequently limited because of reduced FEV1 and safety concerns. Therefore, alternative strategies to identify ways to minimize the allergenicity of immunotherapy while improving the effectiveness are currently being investigated in animal models of asthma and in human subjects with allergic rhinitis. Several DNA-based methods of immunization (CpG DNA, CpG DNA conjugated to a protein allergen, and plasmid DNA) have shown promise in animal models of asthma, and some of these DNA-based therapies have entered phase I/II clinical trials. Furthermore, ongoing large-scale phase III clinical trials will be able to determine whether any of these DNA-based therapies are safe and effective to use in subjects with allergic rhinitis and asthma.
Document Type: Review Article
Publication date: May-June 2005
- Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.
The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.
Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.
Articles marked "F" offer free full text for personal noncommercial use only.
The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
- Editorial Board
- Information for Authors
- Submit a Paper
- Information for Advertisers
- Reprint Requests
- ingentaconnect is not responsible for the content or availability of external websites